Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $19.65 $24.19 Monday, 13th May 2024 PRTA stock ended at $20.71. This is 2.95% less than the trading day before Friday, 10th May 2024. During the day the stock fluctuated 5.72% from a day low at $20.65 to a day high of $21.83.
90 days $19.65 $31.01
52 weeks $19.65 $77.11

Historical Prothena Corporation plc prices

Date Open High Low Close Volume
Nov 10, 2023 $33.21 $33.94 $32.16 $33.32 559 470
Nov 09, 2023 $35.67 $35.76 $32.22 $32.76 603 350
Nov 08, 2023 $36.16 $37.27 $34.57 $35.31 513 112
Nov 07, 2023 $36.19 $37.25 $35.77 $36.42 546 187
Nov 06, 2023 $37.94 $37.94 $35.16 $35.73 843 889
Nov 03, 2023 $38.46 $40.60 $36.72 $37.55 957 426
Nov 02, 2023 $36.78 $36.80 $34.73 $34.96 784 779
Nov 01, 2023 $36.03 $36.93 $35.33 $36.68 746 027
Oct 31, 2023 $35.42 $36.92 $34.40 $36.46 716 822
Oct 30, 2023 $36.01 $36.86 $34.14 $35.47 848 024
Oct 27, 2023 $34.13 $36.93 $33.38 $35.75 1 528 215
Oct 26, 2023 $37.78 $37.78 $28.51 $33.88 4 201 805
Oct 25, 2023 $41.27 $42.44 $39.60 $39.68 758 685
Oct 24, 2023 $42.98 $43.29 $41.70 $42.25 544 778
Oct 23, 2023 $43.62 $44.20 $42.24 $42.26 601 521
Oct 20, 2023 $44.54 $44.78 $43.49 $43.79 567 701
Oct 19, 2023 $45.37 $45.93 $44.44 $44.60 430 945
Oct 18, 2023 $46.16 $46.22 $43.93 $44.91 720 820
Oct 17, 2023 $52.27 $53.23 $46.51 $47.13 1 231 305
Oct 16, 2023 $44.10 $55.88 $44.10 $52.32 2 855 797
Oct 13, 2023 $46.22 $46.22 $43.60 $44.08 553 576
Oct 12, 2023 $46.99 $47.36 $45.37 $45.92 605 500
Oct 11, 2023 $47.29 $49.20 $46.24 $47.17 204 190
Oct 10, 2023 $47.56 $48.80 $47.16 $47.30 383 513
Oct 09, 2023 $46.75 $48.19 $46.10 $47.40 379 238
Click to get the best stock tips daily for free!

About Prothena Corporation plc

Prothena  plc Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease... PRTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT